EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: A case-control study

Multiple Sclerosis

Volumn 14, Issue 8, 2008, Pages 1120-1122

  Sundström, Peter ^a   Nystrom L ^b   Jidell, E ^a   Hallmans, G ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

1501; EBNA 1; Epstein barr virus; HLA DRB1; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; HLA DR ANTIGEN; UNCLASSIFIED DRUG; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; HLA DRB1*1501, HUMAN; HLA-DRB1*1501, HUMAN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE INTERACTION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RISK ASSESSMENT; RISK FACTOR; BLOOD; IMMUNOLOGY; MULTIVARIATE ANALYSIS; SWEDEN; VIROLOGY;

CASE-CONTROL STUDIES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; RISK FACTORS; SWEDEN;

EID: 58149348645     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508092353     Document Type: Article

References (10)

1. Schmidt, H, Williamson, D, Ashley-Koch, A. HLA-DR15 haplotype and multiple sclerosis: A Huge review. Am J Epidemiol 2007; 165: 1097-1109.
2. Ramagopalan, SV, Morris, AP, Dyment, DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007; 3: 1607-1613.
3. Sumaya, CV, Myers, LW, Ellison, GW. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 1980; 37: 94-96.
4. Ascherio, A, Munger, KL, Lennette, ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study. JAMA 2001; 286: 3083-3088.
5. Sundstrom, P, Juto, P, Wadell, G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study. Neurology 2004; 62: 2277-2282.
6. Sundstrom, P, Nystrom, L, Forsgren, L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 2003; 74: 29-32.
7. Olerup, O, Aldener, A, Fogdell, A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119-134.
8. Nielsen, TR, Rostgaard, K, Nielsen, NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64: 72-75.
9. Serafini, B, Rosicarelli, B, Franciotta, D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899-2912.
10. Sharipo, A, Imreh, M, Leonchiks, A, Imreh, S, Masucci, MG. A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: A new mechanism for selective inhibition of proteolysis. Nat Med 1998; 4: 939-944.